Skip to main content

Advertisement

SpringerLink
Log in

Peritoneal Carcinomatosis from Gastric Cancer: Current Considerations for Systematic Management and Future Tendencies for Identification of Valid Predictors

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sun Z, Xu YY, Wang ZN, et al. Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery. Ann Surg Oncol. 2011;18:1068–80.

    Article  PubMed  Google Scholar 

  2. Roviello F, Marrelli D, de Manzoni G, et al. Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg. 2003;90:1113–9.

    Article  PubMed  CAS  Google Scholar 

  3. Yan TD, Black D, Sugarbaker PH, et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol. 2007;14:2702–13.

    Article  PubMed  Google Scholar 

  4. Sobin L, Gospodarowicz M, Wittekind C, eds. TNM classification of malignant tumours. 7th ed. International Union Against Cancer (UICC). New York: Wiley, 2009.

    Google Scholar 

  5. Yu W, Whang I, Suh I, Averbach A, Chang D, Sugarbaker PH. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg. 1998;228:347–54.

    Article  PubMed  CAS  Google Scholar 

  6. Yonemura Y, Kawamura T, Bandou E, et al. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg. 2005;92:370–5.

    Article  PubMed  CAS  Google Scholar 

  7. Glehen O, Schreiber V, Cotte R, et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg. 2004;139:20–6.

    Article  PubMed  CAS  Google Scholar 

  8. Okabe H, Ueda S, Obama K, Hosogi H, Sakai Y. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. Ann Surg Oncol. 2009;16:3227–36.

    Article  PubMed  Google Scholar 

  9. Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18:1575–81.

    Article  PubMed  Google Scholar 

  10. Fujiwara Y, Takiguchi S, Nakajima K, et al. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination. Ann Surg Oncol. 2011. DOI:10.1245/s10434-011-1770-8.

  11. Chua TC, Yan TD, Saxena A, Morris DL. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality. Ann Surg. 2009;249:900–7.

    Article  PubMed  Google Scholar 

  12. Kodera Y, Yamamura Y, Shimizu Y, et al. Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol. 1999;72:60–4.

    Article  PubMed  CAS  Google Scholar 

  13. Homma Y, Ushida S, Yamada M, Kobayashi H, Suzuki K. Positive peritoneal washing cytology in multiple cavities can predict poor prognosis of advanced gastric cancer patients. Ann Surg Oncol. 2010;17:455–60.

    Article  PubMed  Google Scholar 

  14. Benevolo M, Mottolese M, Cosimelli M, et al. Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer. J Clin Oncol. 1998;16:3406–11.

    PubMed  CAS  Google Scholar 

  15. Bonenkamp JJ, Songun I, Hermans J, van de Velde CJ. Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg. 1996;83:672–4.

    Article  PubMed  CAS  Google Scholar 

  16. Abe S, Yoshimura H, Tabata H, et al. Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome. J Surg Oncol. 1995;59:226–9.

    Article  PubMed  CAS  Google Scholar 

  17. Kodera Y, Nakanishi H, Ito S, et al. Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction: a sensitive predictor of outcome for patients with gastric carcinoma. Ann Surg. 2002;235:499–506.

    Article  PubMed  Google Scholar 

  18. Nakanishi H, Kodera Y, Yamamura Y, et al. Rapid quantitative detection of carcinoembryonic antigenexpressing free tumor cells in the peritoneal cavity of gastric cancer patients with real-time RT-PCR on the lightcycler. Int J Cancer. 2000;89:411–7.

    Article  PubMed  CAS  Google Scholar 

  19. Ito S, Nakanishi H, Kodera Y, Mochizuki Y, Tatematsu M, Yamamura Y. Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients. Br J Cancer. 2005;93:986–92.

    Article  PubMed  CAS  Google Scholar 

  20. Li X, Zhang Y, Zhang Y, Ding J, Wu K, Fan D. Survival prediction of gastric cancer by a seven-microRNA signature. Gut. 2010;59:579–85.

    Article  PubMed  CAS  Google Scholar 

  21. Ueda T, Volinia S, Okumura H, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010;11:136–46.

    Article  PubMed  CAS  Google Scholar 

  22. Zhang X, Yan Z, Zhang J, et al. Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Ann Oncol. 2011. DOI:10.1093/annonc/mdq758.

  23. Roukos DH. Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery. Expert Rev Mol Diagn. 2008;8:587–97.

    Article  PubMed  Google Scholar 

  24. Roukos DH, Lykoudis E, Liakakos T. Genomics and challenges toward personalized breast cancer local control. J Clin Oncol. 2008;26:4360–1.

    Article  PubMed  Google Scholar 

  25. Sakamoto H, Yoshimura K, Saeki N, et al; Study Group of Millennium Genome Project for Cancer. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet. 2008;40:730–40.

    Article  PubMed  CAS  Google Scholar 

  26. Song HR, Kim HN, Piao JM, et al. Association of a common genetic variant in prostate stem-cell antigen with gastric cancer susceptibility in a korean population. Mol Carcinog. 2011. DOI:10.1002/mc.20796.

  27. Wu C, Wang G, Yang M, et al. Two genetic variants in prostate stem cell antigen and gastric cancer susceptibility in a Chinese population. Mol Carcinog. 2009;48:1131–8.

    Article  PubMed  CAS  Google Scholar 

  28. Wang M, Bai J, Tan Y, et al. Genetic variant in PSCA predicts survival of diffuse-type gastric cancer in a Chinese population. Int J Cancer. 2010. DOI:10.1002/ijc.25740.

  29. Abnet, CC, Freedman ND, Hu N, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet. 2010;42:764–7.

    Article  PubMed  CAS  Google Scholar 

  30. Zhang H, Jin G, Li H, et al. Genetic variants at 1q22 and 10q23 reproducibly associated with gastric cancer susceptibility in a Chinese population. Carcinogenesis. 2011;32:848–52.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

Supported by grants from the National Natural Science Foundation of China (30901419).

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China

    Zhe Sun MD & Hui-Mian Xu MD

Authors
  1. Zhe Sun MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hui-Mian Xu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hui-Mian Xu MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sun, Z., Xu, HM. Peritoneal Carcinomatosis from Gastric Cancer: Current Considerations for Systematic Management and Future Tendencies for Identification of Valid Predictors. Ann Surg Oncol 18 (Suppl 3), 202–205 (2011). https://doi.org/10.1245/s10434-011-1853-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-011-1853-6

Keywords

Search

Navigation